The influence of pregnancy on the development of autoimmunity in chronic lymphocytic leukemia

References

• Cheson B D, Bennett J M, Grever M, Kay N, Keating M J, O'Brien S, Rai K R. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukaemia, revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
   PubMed Web of Science ®Google Scholar
• Hamblin T J, Davis Z, Gardiner A, Oscier D G, Stevenson F K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukaemia. Blood 1999; 94: 1848–1854
   PubMed Web of Science ®Google Scholar
• Döhner H, Stilgenbauer S, Benne A, Leupol E, Kröbe A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukaemia. N Engl J Med 2000; 343: 1580–1588
   Web of Science ®Google Scholar
• Muller-Hermelink H K, Catovsky D, Montserrat E, Harris N L. Chronic lymphocytic leukemia/small lymphocytic lymphoma. Tumours of haematopoietic and lymphoid tissues, E Jaffe, N L Harris, H Stein, J Vardiman. IARC Press, Lyon 2001; 127–130
   Google Scholar
• Chiorazzi N, Rai K R, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815
   PubMed Web of Science ®Google Scholar
• Isaacson P, Spencer J. Autoimmunity and malignancy. Autoimmune disease. Focus on Sjögren's syndrome, D A Isenberg, A Horsfall. Bios, Oxford 1994; 189–204
   Google Scholar
• Dighiero G, Rose N R. Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity. Immunol Today 1999; 20: 323–328
   PubMedGoogle Scholar
• Hamblin T. Autoimmune disease and its management in chronic lymphocytic leukemia. Chronic lymphoid leukemias, B D Cheson. Marcel Dekker, New York 2001; 435–458
   Google Scholar
• Brusic V, Rudy G, Harrison L. Molecular mimicry: from hypothesis towards evidence. Immunol Today 1997; 18: 95–96
   PubMedGoogle Scholar
• Cohen I R. Principles of molecular mimicry and autoimmune disease. Molecular mimicry, microbes and autoimmunity, M W Cunningham, R S Fujinami. AMS Press, Washington, DC 2000; 17–26
   Google Scholar
• Weiss R B, Freiman J, Kweder S L, Diehl L F, Byrd J C. Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. J Clin Oncol 1998; 16: 1885–1889
   PubMed Web of Science ®Google Scholar
• Catovsky D, Richards S. Incidence of hemolytic anemia after chemotherapy in the CLL4 trial. A possible protective role for fludarabine plus cyclophosphamide. Blood 2004; 104: 141a
   Web of Science ®Google Scholar
• Hervé M, Xu K, Ng Y S, Wardemann H, Albesiano E, Messmer B T, et al. Unmutated and mutated chronic lymphocytic leukemia derived from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 2005; 115: 1636–1643
   PubMed Web of Science ®Google Scholar
• Mauro F R, Foa R, Cerretti R, Giannarelli D, Coluzzi S, Mandelli F, Girelli G. Autoimmune hemolytic anemia in chronic lymphocytic leukemia, clinical, therapeutical, and prognostic features. Blood 2000; 95: 2786–2792
   PubMed Web of Science ®Google Scholar
• Kyasa M J, Parrish R S, Schichman S A, Zent C S. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 2003; 74: 1–8
   PubMed Web of Science ®Google Scholar
• Nelson J L. Microchimerism, incidental byproduct of pregnancy or active participant in human health?. Trends Mol Med 2002; 8: 109–113
   PubMed Web of Science ®Google Scholar
• Olsen N J, Kovacs W J. Hormones, pregnancy, and rheumatoid arthritis. J Gend Specif Med 2002; 5: 28–37
   PubMedGoogle Scholar
• Nelson J L. Pregnancy and microchimerism in autoimmune disease, protector or insurgent?. Arthritis Rheum 2002; 46: 291–297
   PubMed Web of Science ®Google Scholar
• Nelson J L. Microchimerism and human autoimmune diseases. Lupus 2002; 11: 651–654
   Google Scholar
• Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999; 20: 114–118
   PubMedGoogle Scholar
• Hanson LÅ. The mother – offspring dyad and the immune system. Acta Pædiatr 2000; 89: 252–258
   PubMed Web of Science ®Google Scholar
• Bianchi D W, Zickwolf G K, Weil G J, Sylvester S, DeMaria M A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci 1996; 93: 705–709
   PubMed Web of Science ®Google Scholar
• Maloney S, Smith A, Furst D E, Myerson D, Rupert K, Evans P C, Nelson J L. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999; 104: 41–47
   PubMed Web of Science ®Google Scholar
• Burastero S E, Galbiati S, Vassallo A, Sabbadini M G, Bellone M, Marchionni L, et al. Cellular microchimerism as a lifelong physiologic status in parous women. An immunologic basis for its amplification in patients with systemic sclerosis. Arthritis Rheum 2003; 48: 1109–1116
   PubMed Web of Science ®Google Scholar
• Srivatsa B, Srivatsa S, Johnson K L, Bianchi D W. Maternal cell microchimerism in newborn tissues. J Pediatr 2003; 142: 31–35
   PubMed Web of Science ®Google Scholar
• Khosrotehrani K, Bianchi D W. Fetal cell microchimerism, helpful or harmful to the parous woman?. Curr Opin Obstet Gynecol 2003; 15: 195–199
   PubMed Web of Science ®Google Scholar
• Nelson J L. Microchimerism and autoimmune disease. N Engl J Med 1998; 338: 1224–1225
   PubMed Web of Science ®Google Scholar
• Lambert N C, Stevens A M, Tylee T S, Erickson T D, Furst D E, Nelson J L. From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis. Ann NY Acad Sci 2001; 945: 164–171
   PubMed Web of Science ®Google Scholar
• Lambert N, Nelson J L. Microchimerism in autoimmune disease, more questions than answers?. Autoimmunity Rev 2003; 2: 133–139
   PubMed Web of Science ®Google Scholar
• Adams K M, Nelson J L. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004; 291: 1127–1131
   PubMed Web of Science ®Google Scholar
• Sarkar K, Miller F W. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev 2004; 3: 454–463
   PubMed Web of Science ®Google Scholar
• Artlett C M, Smith J B, Jimenez S A. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998; 338: 1186–1191
   PubMed Web of Science ®Google Scholar
• Lambert N C, Dennis Lo Y M, Erickson T D, Tylee T S, Githrie K A, Furst D E, Nelson J L. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 2002; 100: 2845–2851
   PubMed Web of Science ®Google Scholar
• Corpechot C, Barbu V, Chazouilleres O, Poupon R. Fetal microchimerism in primary biliary cirrhosis. J Hepatol 2000; 33: 696–700
   PubMed Web of Science ®Google Scholar
• Parikh-Patel A, Gold E, Utts J, Gershwin M E. The association between gravidity and primary biliary cirrhosis. Ann Epidemiol 2002; 12: 264–272
   PubMed Web of Science ®Google Scholar
• Srivatsa B, Srivatsa S, Johnson K L, Samura O, Lee S L, Bianchi D W. Microchimerism of presumed fetal origin in thyroid specimens from women: a case – control study. Lancet 2001; 358: 2034–2038
   PubMed Web of Science ®Google Scholar
• Ando T, Davies T F. Postpartum autoimmune thyroid disease, the potential role of fetal microchimerism. J Clin Endocrinol Metab 2003; 88: 2965–2971
   PubMed Web of Science ®Google Scholar
• Endo Y, Negishi I, Ishikawa O. Possible contribution of microchimerism to the pathogenesis of Sjögren's syndrome. Rheumatology 2002; 41: 490–495
   PubMed Web of Science ®Google Scholar
• Kuroki M, Okayama A, Nakamura S, Sasaki T, Murai K, Shiba R, et al. Detection of maternal – fetal microchimerism in the inflammatory lesions of patients with Sjögren's syndrome. Ann Rheum Dis 2002; 61: 1041–1046
   PubMed Web of Science ®Google Scholar
• Dijk B A van, Boomsma D I, Man A JM de. Blood group chimerism in human multiple births is not rare. Am J Med Genet 1996; 61: 264–268
   PubMed Web of Science ®Google Scholar
• Hoppe B, Stibbe W, Bielefeld A, Preuss A, Salama A. Increased RBC autoantibody production in pregnancy. Transfusion 2001; 41: 1559–1561
   PubMed Web of Science ®Google Scholar
• Johnson K L, McAlindon T E, Mulcahy E, Bianchi D W. Microchimerism in female patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2107–2111
   PubMed Web of Science ®Google Scholar
• Reed A M, Picornell Y J, Harwood A, Kredich D W. Chimerism in children with juvenile dermatomyositis. Lancet 2000; 356: 2156–2157
   PubMed Web of Science ®Google Scholar
• van Venrooij W J, Maini R N. Manual of biological markers of disease. Kluwer, Dordrecht 1993
   Google Scholar
• Wiik A S, Gordon T P, Kavanaugh A F, Lahita R G, Reeves W, van Venrooij W J, et al. Cutting edge diagnostic in rheumatology, the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum 2004; 51: 291–298
   PubMed Web of Science ®Google Scholar
• Klippel J H. Primer on the rheumatic diseases 12th ed. Arthritis Foundations, Atlanta 2001; 8–700
   Google Scholar
• Isaacson P G. Gastrointestinal lymphomas and lymphoid hyperplasias. Neoplastic hematopathology 2nd ed, D M Knowles. Lippincott Williams & Wilkins, Philadelphia 2001; 1235–1261
   Google Scholar
• Arnett F C, Edworthy S M, Bloch D A, McShane D J, Fries J F, Cooper N S, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324
   PubMed Web of Science ®Google Scholar
• Tan E M, Cohen A S, Fries J F, Masi A T, McShane D J, Rothfield N F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Carmel R. Megaloblastic anemias, disorders of impaired DNA synthesis. Wintrobe's haematology 11th ed, J P Greer, J Foerster, J N Lukens, G M Rodgers, F Paraskevas, B Glader. Lippincott Williams & Wilkins, Philadelphia 2004; 1367–1395
   Google Scholar
• Ludwig J. Terminology of chronic hepatitis, hepatic allograft-rejection, and nodular lesions of the liver, summary of recommendations developed by an international working party. Am J Gastroenterol 1994; 89: S177–S181
   PubMed Web of Science ®Google Scholar
• Wilson W A, Gharavi A E, Koike T, Lockshin M D, Branch D W, Piette J C, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome, report of an international workshop. Arthritis Rheum 1999; 42: 1309–1311
   PubMed Web of Science ®Google Scholar
• Hilden J, Jønsson V, Wiik A. Pregnancy as exposure: a Mendelian model of the impregnator load as a trigger of foetus-vs.-mother processes, autoimmunity and leukaemia. Contr Clin Trials 2003; 24: 93S
   Google Scholar
• Birth statistics in Denmark. National Board of Health, Vital Statistic I. State Publications of Denmark, Copenhagen 1994/95
   Google Scholar
• Bracero L A, Cassidy S, Byrne D W. Effect of gender on perinatal outcome in pregnancies complicated by diabetes. Gynecol Obstet Invest 1996; 41: 10–14
   PubMed Web of Science ®Google Scholar
• Kramer M S, Usher R H, Pollack R, Boyd M, Usher S. Etiologic determinants of abruptio placentae. Obstet Gynecol 1997; 89: 221–226
   PubMed Web of Science ®Google Scholar
• Bottoms S F, Paul R H, Mercer B M, MacPherson C A, Caritis S N, Moaward A H, et al. Obstetric determinants of neonatal survival: antenatal predictors of neonatal survival and morbidity in extremely low birth weight infants. Am J Obstet Gynecol 1999; 180: 665–669
   PubMed Web of Science ®Google Scholar
• Basso O, Olsen J. Sex ratio and twinning in woman with hyperemesis or preeclampsia. Epidemiology 2001; 12: 747–779
   PubMed Web of Science ®Google Scholar
• Haddad B, Mercer B M, Livingston J C, Sibai B M. Obstetric antecedents to apparent stillbirth (Apgar score zero at 1 minute only). Obstet Gynecol 2001; 97: 961–964
   PubMed Web of Science ®Google Scholar
• Helle S, Lummaa V, Jokela J S. Sons reduced maternal longevity in preindustrial humans. Science 2002; 296: 1085
   PubMed Web of Science ®Google Scholar